Related Experiment Video
Updated: Nov 12, 2025

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
Nano-Medicine in the Cardiovascular System
Danielle Pretorius1,2, Vahid Serpooshan3, Jianyi Zhang1,2
1Department of Biomedical Engineering, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Nano-medicines offer promising cardiovascular therapies by leveraging unique nanomaterial properties for improved cellular responses. Understanding these nanomaterials is key for their successful clinical translation in cardiac applications.
Area of Science:
- Biomedical Engineering
- Cardiovascular Medicine
- Nanotechnology
Background:
- Nano-medicines, including nanoparticles and exosomes, are emerging as potent therapeutic sources for cardiovascular dysfunction.
- Nanomaterials offer unique physicochemical properties and surface characteristics that can elicit beneficial cellular responses within the cardiovascular system.
Purpose of the Study:
- To review current nano-medicine systems explored in the cardiac field.
- To highlight differences between these systems and their impact on therapeutic/diagnostic applications.
- To discuss key concerns including cellular responses, toxicity, and regenerative capabilities.
Main Methods:
- Literature review of nano-medicine applications in cardiology.
- Analysis of nanomaterial properties and their effects on cardiovascular systems.
- Discussion of current research and development in cardiac nano-medicine.
Main Results:
- Various nano-medicine systems are under investigation for cardiac applications.
- Differences in nanomaterial properties influence specific therapeutic and diagnostic outcomes.
- Nanomaterials show potential for cardio-protection and regeneration.
Conclusions:
- Nano-medicines represent a significant advancement for cardiovascular therapies and diagnostics.
- A thorough understanding of nanomaterial-biomedical interactions is crucial for clinical translation.
- Further research into safety and efficacy is essential for cardiac nano-medicine development.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pathophysiology of Cardiac Performance
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

